Viewing StudyNCT05925127



Ignite Creation Date: 2024-05-06 @ 7:10 PM
Last Modification Date: 2024-10-26 @ 3:02 PM
Study NCT ID: NCT05925127
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-31
First Post: 2023-06-27

Brief Title: Phase 23 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines
Sponsor: Novavax
Organization: Novavax

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-10-16
Start Date Type: ACTUAL
Primary Completion Date: 2024-05-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-11-14
Completion Date Type: ESTIMATED
First Submit Date: 2023-06-27
First Submit QC Date: June 27 2023
Study First Post Date: 2023-06-29
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-29
Last Update Post Date: 2024-05-31
Last Update Post Date Type: ACTUAL